Brian Skorney | Analyst | Dyne Therapeutics, Inc.

Skip to main navigation

Skip to main content

About Us
Overview Leadership Board of directors Scientific advisory board Corporate Responsibility Contact us
FORCE^TM Platform
Overview Scientific publications & presentations
Pipeline
Overview Zeleciment rostudirsen (DYNE-251) Zeleciment basivarsen (DYNE-101) DYNE-302
Physicians
Patients
Commitment Clinical trials DMD stories DM1 stories FSHD stories Resources
Investors & Media
Company overview News, publications & events Stock information Corporate governance Financials & filings IR resources
Culture & Careers
Our culture & values Hear from our Dynamos Competitive benefits Open positions

Open navigation

About Us FORCE^TM Platform Pipeline Physicians Patients Investors & Media Culture & Careers

Overview
Leadership
Board of directors
Scientific advisory board
Corporate Responsibility
Contact us

about-us

Overview
Scientific publications & presentations

force™-platform

Overview
Zeleciment rostudirsen (DYNE-251)
Zeleciment basivarsen (DYNE-101)
DYNE-302

pipeline

physicians

Commitment
Clinical trials
DMD stories
DM1 stories
FSHD stories
Resources

patients

Company overview
News, publications & events
Stock information
Corporate governance
Financials & filings
IR resources

investors--media

Our culture & values
Hear from our Dynamos
Competitive benefits
Open positions

culture--careers

Stay in Touch

info@dyne-tx.com 781.786.8230
781.786.8230
linkedin.com twitter.com facebook.com youtube.com

Poised to address unmet need in neuromuscular diseases and

positioned for growth

Brian Skorney

Robert W. Baird & Co.

Contact IR

RSS

Email Alerts

Stay in touch

info@dyne-tx.com 781.786.8230
781.786.8230
linkedin.com twitter.com facebook.com youtube.com

Privacy Policy
© 2026 Dyne Therapeutics, Inc.

You are now leaving
the Dyne Therapeutics corporate website